Healthcare
JNJ Stock Analysis
Johnson & Johnson · current price $268.02 (+0.85% today)
Top-tier setup — 3/4 EPS beats, 21% net margin. Momentum, fundamentals and macro indicators are aligned.
★★★★★
Top Tier
JNJ Stock AnalysisJohnson & Johnson · current price $268.02 (+0.85% today)
Each pillar is scored 0-100 inside the stock’s own peer group, so a chipmaker is measured against chipmakers. These are quality descriptors, not buy or sell signals.
Reading JNJ’s price and volume history…
Checking the areas that decide this thesis…
AI-generated from the company’s own filings and recent coverage, and it can be incomplete or wrong. A PASS is a reading of the cited evidence, not a verified fact and not a reason to buy. Follow each citation to the source.
Reading JNJ’s filings…
| Quarter | EPS | Est. | Surprise | Result |
|---|---|---|---|---|
| 2025-09-30 | $2.80 | $2.76 | +1.5% | Beat |
| 2025-12-31 | $2.46 | $2.46 | -0.1% | Miss |
| 2026-03-31 | $2.70 | $2.68 | +0.8% | Beat |
| 2026-06-30 | $2.90 | $2.85 | +1.6% | Beat |
Johnson & Johnson (JNJ) currently has a TickerMover Quant Score of 68/100, rated ★★★★★ Top Tier. The Quant Score is a quantitative composite across six research pillars — momentum, quality, growth, valuation, sentiment and risk. It is research information, not investment advice.
TickerMover does not give buy or sell recommendations. JNJ scores 68/100 (★★★★★ Top Tier) on our quantitative research model — a screening signal, not a personal recommendation. Do your own research, and consider an FCA-authorised adviser before investing.
JNJ's Quant Score and underlying data refresh through US market hours (about every five minutes), using public market and fundamental data.
Real-time scoring, conflict detection, Reverse DCF and peer comparison — free while in beta.
Open the dashboard for JNJ →
